Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Genome Editing/Genome Engineering Market Forecast: What Value Will The Market Reach By 2030?
The genome editing/genome engineering market has witnessed rapid expansion in recent years. It is anticipated to expand from $10.17 billion in 2025 to $12.15 billion in 2026, achieving a compound annual growth rate (CAGR) of 19.5%. This historical growth can be attributed to key factors including the discovery of genome editing techniques, their initial applications in research, the widespread availability of molecular biology tools, an increase in academic research funding, and the growing demand for disease modeling.
The genome editing/genome engineering market is projected for substantial expansion in the coming years. It is forecast to achieve a size of $24.53 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 19.2%. This anticipated growth can be attributed to the clinical translation of gene editing therapies, the broadening field of agricultural genomics, enhancements in editing accuracy, the creation of ethical frameworks, and the commercialization of genome editing services. Significant trends during the forecast period involve the rising adoption of CRISPR-based editing tools, the wider application of genome editing in disease research, an increased utilization of cell line engineering applications, a growing need for precision gene modification, and augmented academic and government research funding.
Get A Free Sample Report With In-Depth Market Insights:
Genome Editing/Genome Engineering Market Growth Factors: What’s Supporting Expansion?
The genome editing and genome engineering market’s growth is projected to be propelled by an escalation in research pursuits. These pursuits involve systematic and organized efforts undertaken by individuals, teams, or institutions to collect, analyze, interpret, and generate new knowledge or insights in a particular field of study. Genome editing and genome engineering have become pivotal catalysts in the expanding volume of research activities, significantly transforming the landscape of scientific exploration. These groundbreaking tools empower researchers to meticulously modify and comprehend the intricate genetic fabric of organisms, offering unparalleled precision and versatility. For instance, in July 2023, according to National Institute of Neurological Disorders and Stroke, a US-based government research institute, reported that NIH awards more than $140 million to help accelerate genome editing approaches from the lab to the clinic. Therefore, an increase in research activities is driving the genome editing and genome engineering market.
Genome Editing/Genome Engineering Market Segment Breakdown: Which Categories Lead On Revenue?
The genome editing/genome engineering market covered in this report is segmented –
1) By Product And Service: Reagents And Consumables, Software And Systems, Services
2) By Technology: CRISPR, TALEN, ZFN, Antisense, Other Technologies
3) By Application: Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery And Development, Other Applications
4) By End User: Biotechnology Companies, Pharmaceutical Companies, Academic And Government Research Institutes
Subsegments:
1) By Reagents And Consumables: CRISPR Or Cas9 Kits, TALENs Kits, Zinc Finger Nucleases (ZFNs), Donor DNA Templates, Nucleotide Reagents
2) By Software And Systems: Genome Editing Design Software, Analysis And Visualization Tools, Workflow Management Systems
3) By Services: Gene Synthesis And Cloning Services, Custom Genome Editing Services, Consulting Services For Genome Editing Projects
Genome Editing/Genome Engineering Market Trends Shaping Long-Term Demand
Major companies are engaging in collaborations and partnerships to strengthen their standing in the genome editing and genome engineering market. A strategic business partnership refers to a structured affiliation between two or more commercial enterprises, typically formalized through one or more business agreements or contracts. For instance, in April 2024, Regeneron Pharmaceuticals, a US-based biopharmaceutical company focused on developing medicines in immunology, oncology, and genetic diseases, entered into a collaboration with Mammoth Biosciences, a US-based biotech firm founded by Jennifer Doudna that specializes in CRISPR-based gene editing. Through this partnership, Regeneron aims to leverage Mammoth’s ultra-small CRISPR platforms together with Regeneron’s delivery technologies to accelerate the development of in vivo gene editing therapies for tissues beyond the liver, thereby expanding Regeneron’s therapeutic pipeline and technological reach. Mammoth Biosciences is a U.S.-based company providing CRISPR-based genome editing systems, including its proprietary small Cas enzymes, for therapeutic and diagnostic applications.
Genome Editing/Genome Engineering Market Leading Players And Competitive Positioning
Major companies operating in the genome editing/genome engineering market are Thermo Fisher Scientific Inc., Merck Group, Genscript Biotech Corp, Sangamo Therapeutics Inc., Lonza Group AG, Editas Medicine Inc., CRISPR Therapeutics AG, Agilent Technologies Inc., Intellia Therapeutics, bluebird bio Inc., Transposagen Biopharmaceuticals Inc., Tecan Trading AG, Precision BioSciences, PerkinElmer Inc., Cellectis S.A, Applied StemCell Inc., Bio-Rad Laboratories Inc., Bio-Techne, Creative Biogene, Cyagen Biosciences, Dharmacon Inc., Eurofins Genomics LLC, Evotec SE, GeneCopoeia Inc., Genewiz, Horizon Discovery Group PLC, Inscripta Inc., Integrated DNA Technologies Inc., MaxCyte Inc., New England Biolabs, Novartis International AG.
View The Full Genome Editing/Genome Engineering Market Report:
Genome Editing/Genome Engineering Market Global Footprint: Which Region Leads The Market?
North America was the largest region in the gene editing/genome engineering market in 2025. Asia-Pacific is expected to be the fastest-growing region in the genome editing/genome engineering market report during the forecast period. The regions covered in the genome editing/genome engineering market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model









